| Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | DOJ_CIVIL | $58,650,000 |
| Mylan Inc. | Viatris | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
| Aegerion Pharmaceuticals Inc. | Amryt Pharma | drug or medical equipment safety violation | 2017 | DOJ_CIVIL | $35,000,000 |
| Alere Inc. | Abbott Laboratories | accounting fraud or deficiencies | 2017 | SEC | $13,023,885 |
| Aegerion Pharmaceuticals | Amryt Pharma | investor protection violation | 2017 | SEC | $4,100,000 |
| Galena Biopharma Inc. | SELLAS Life Sciences Group | False Claims Act and related | 2017 | USAO | $7,550,000 |
| Celgene Corp. | Bristol-Myers Squibb | False Claims Act and related | 2017 | USAO | $280,000,000 |
| Aldrich Chemical Company LLC | Merck KGaA (EMD) | tax violations | 2017 | ATTTB | $22,500 |
| United Therapeutics Corporation | United Therapeutics | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
| Cytrx Corporation | CytRx | investor protection violation | 2017 | SEC | $75,000 |
| General Nutrition Corporation | Harbin Pharmaceutical Group | wage and hour violation | 2017 | MA-AG | $72,304 |
| SIGMA-ALDRICH, INC | Merck KGaA (EMD) | aviation safety violation | 2017 | FAA | $5,000 |
| Pharmavite LLC | Otsuka Pharmaceutical | wage and hour violation | 2017 | private lawsuit-state | $1,925,000 |
| Amgen, Inc. | Amgen | benefit plan administrator violation | 2017 | private lawsuit-federal | $2,750,000 |
| Aegerion Pharmaceuticals Inc. | Amryt Pharma | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
| Alere Inc. | Abbott Laboratories | kickbacks and bribery | 2017 | MS-AG | $2,000,000 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
| Celgene Corp. | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
| Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2017 | MULTI-AG | $33,000,000 |
| Mallinckrodt plc | Mallinckrodt | price-fixing or anti-competitive practices | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000 |
| Mylan Inc. | Viatris | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
| Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
| Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
| UCB Holdings, Inc. | UCB | benefit plan administrator violation | 2017 | private lawsuit-federal | $5,500,000 |
| Valeant Pharmaceuticals International, Inc. | Bausch Health | investor protection violation | 2017 | MULTI-AG | $145,000,000 |
| Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2017 | CA-INS | $1,100,000 |
| MERCK SHARP & DOHME CORP | Merck | environmental violation | 2017 | NJ-ENV | $6,000 |
| Phibro-Tech Inc | Phibro Animal Health | environmental violation | 2017 | CA-SCAQMD | $19,000 |
| Baxalta US, Inc. | Takeda Pharmaceutical | environmental violation | 2017 | CA-SCAQMD | $35,000 |
| Endo International PLC | Endo International | drug or medical equipment safety violation | 2017 | private lawsuit-federal | $775,000,000 |
| Daiichi Sankyo Inc. | Daiichi Sankyo | product safety violation | 2017 | private lawsuit-federal | $300,000,000 |
| Endo Health Solutions Inc. | Endo International | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
| Allergan | AbbVie | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $15,000,000 |
| Barr Laboratories Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-state | $225,000,000 |
| Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
| Lupin Ltd. | Lupin Limited | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $625,000 |
| Lupin Ltd. | Lupin Limited | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,143,750 |
| Merck & Co. | Merck | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $60,200,000 |
| Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,750,000 |
| Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $3,202,500 |
| Sanofi Pasteur Inc. | Sanofi | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $61,500,000 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $6,750,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $5,000,000 |
| Pharmavite LLC | Otsuka Pharmaceutical | consumer protection violation | 2017 | private lawsuit-federal | $10,975,000 |
| Allergan Usa Inc | AbbVie | wage and hour violation | 2017 | MI-LEO | $64,828 |
| Allergan Inc. | AbbVie | False Claims Act and related | 2017 | private lawsuit-federal | $13,000,000 |
| IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | workplace safety or health violation | 2017 | OSHA | $9,600 |
| AMNEAL PHARMACEUTICALS, LLC | Amneal Pharmaceuticals | workplace safety or health violation | 2017 | OSHA | $6,791 |
| ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2017 | OSHA | $6,518 |
| EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | environmental violation | 2017 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $385,000 |
| Pharmacia and Upjohn Company LLC | Pfizer | environmental violation | 2017 | EPA | $34,170 |
| Novartis AG | Novartis | Foreign Corrupt Practices Act | 2016 | SEC | $25,000,000 |
| SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
| Acclarent Inc. | Johnson & Johnson | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
| Genentech Inc. | Roche | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
| OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
| Pfizer Inc. | Pfizer | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
| GNC Holdings Inc. | Harbin Pharmaceutical Group | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
| Forest Laboratories and Forest Pharmaceuticals | AbbVie | False Claims Act and related | 2016 | DOJ_CIVIL | $38,000,000 |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
| AstraZeneca PLC | AstraZeneca | kickbacks and bribery | 2016 | SEC | $5,522,000 |
| GlaxoSmithKline plc | GlaxoSmithKline | kickbacks and bribery | 2016 | SEC | $20,000,000 |
| Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
| VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | benefit plan administrator violation | 2016 | EBSA | $10,001 |
| Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | USAO | $54,000,000 |
| Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $10,788 |
| Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $12,367 |
| Synthes USA | Johnson & Johnson | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
| General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
| ALDRICH CHEMICAL | Merck KGaA (EMD) | aviation safety violation | 2016 | FAA | $7,500 |
| Abbott Laboratories | Abbott Laboratories | employment discrimination | 2016 | private lawsuit-federal | $210,000 |
| Medicis Pharmaceutical | Bausch Health | employment discrimination | 2016 | private lawsuit-federal | $7,150,000 |
| Daiichi Sankyo | Daiichi Sankyo | employment discrimination | 2016 | private lawsuit-federal | $8,200,000 |
| Novartis Corporation and Alcon Laboratories | Novartis | employment discrimination | 2016 | private lawsuit-federal | $8,000,000 |
| Anda | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
| Cephalon | Teva Pharmaceutical Industries | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
| Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
| Forest Laboratories LLC | AbbVie | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,500,000 |
| Genentech Inc. | Roche | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
| OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
| OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
| Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
| Pfizer Pharmaceuticals, LLC | Pfizer | environmental violation | 2016 | EPA | $190,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
| MERCK SHARP & DOHME CORP | Merck | environmental violation | 2016 | PA-ENV | $6,943 |
| MERCK SHARP & DOHME CORP | Merck | environmental violation | 2016 | PA-ENV | $14,906 |
| GLAXOSMITHKLINE LLC | GlaxoSmithKline | environmental violation | 2016 | PA-ENV | $5,259 |
| AKORN OPERATING COMPANY LLC | Akorn Inc. | environmental violation | 2016 | NJ-ENV | $22,800 |
| MERCK SHARP & DOHME CORP | Merck | environmental violation | 2016 | NJ-ENV | $19,000 |
| ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2016 | NJ-ENV | $99,800 |
| Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $13,250,000 |
| Hoechst Marion Roussel, Inc. | Sanofi | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
| Shire US Inc. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
| Watson Laboratories | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
| Allergan Plc | AbbVie | wage and hour violation | 2016 | MI-LEO | $73,999 |
| Allergan Usa Inc | AbbVie | wage and hour violation | 2016 | MI-LEO | $73,999 |
| Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2016 | private lawsuit-federal | $35,000,000 |
| TEVA PHARMACEUTICAL USA, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2016 | OSHA | $5,000 |
